Following our powder-diffraction study of capecitabine (Rohlicek *et al.*, 2009[@bb3]), Malińska *et al.* (2014[@bb2]) published the crystal structure of the same mol­ecule based on single-crystal data. Although they modelled the wrong enanti­omer \[as was pointed out by Kratochvil *et al.* (2016[@bb1])\], the structures are very similar after inverting the single-crystal structure, including the disordered part of the mol­ecule (Fig. 1[▸](#fig1){ref-type="fig"}). Since single-crystal diffraction is more sensitive to H atoms than powder diffraction, Malinska *et al.* (2014[@bb2]) were able to locate the H atoms directly. This indicated a different tautomeric form of capecitabine to that assumed in our study, and as they pointed out, we had therefore placed one H atom wrongly.

In our defence, in the powder study, we placed the H atoms geometrically according to a reasonable chemical structure for capecitabine, which shows the tautomeric H atom attached to the N atom of the carbamate group and the plausible formation of an inter­molecular N---H⋯O hydrogen bond. As shown by Malińska *et al.* (2014[@bb2]), the H atom is actually located on the N atom of the pyrimidine ring (Fig. 2[▸](#fig2){ref-type="fig"}), thereby forming an intra­molecular N---H⋯O link.

With respect to the fact that structure solution from powder diffraction data is based on the proposed molecular structure, readers should beware of the incorrectly placed H atom in Rohlicek *et al.* (2009[@bb3]) and they should be also beware of the wrong enantiomer in a single-crystal study of Malińska *et al.* (2014[@bb2]).

![Overlay of the capecitabine mol­ecular structures arising from powder diffraction (blue) and from single-crystal diffraction data (red). Only non-H atoms are shown for clarity.](e-72-00879-fig1){#fig1}

![Schemes for the tautomeric forms of capecitabine (*a*) assumed in the powder-diffraction study and (*b*) established in the single-crystal study of Malinska *et al.* (2014[@bb2]).](e-72-00879-fig2){#fig2}
